Shares of Ocugen Inc. /zigman2/quotes/208160861/composite OCGN +5.76% slumped 0.31% to $6.43 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +2.43% rising 1.32% to 4,655.27 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.65% rising 0.68% to 35,135.94. This was the stock's fifth consecutive day of losses. Ocugen Inc. closed $12.34 short of its 52-week high ($18.77), which the company achieved on February 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Adverum Biotechnologies Inc. /zigman2/quotes/210484271/composite ADVM +3.33% fell 3.61% to $1.87, Ocular Therapeutix Inc. /zigman2/quotes/207607068/composite OCUL +2.10% fell 0.31% to $6.52, and Kodiak Sciences Inc. /zigman2/quotes/207655028/composite KOD +5.34% fell 0.01% to $94.29. Trading volume (17.0 M) remained 20.4 million below its 50-day average volume of 37.4 M.